Effects of Prolonged Intensive Lipid-Lowering Therapy on the Characteristics of Carotid Atherosclerotic Plaques In Vivo by MRI
Authors:
Open Access
- 1 October 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 21 (10) , 1623-1629
Abstract
High-resolution magnetic resonance imaging (MRI) with flow suppression not only provides useful information on luminal and wall areas of the carotid artery but also can identify the principal tissue components of the carotid atherosclerotic plaque. The effects of intensive lipid-lowering therapy on these MRI tissue characteristics were examined in patients with coronary disease (CAD). Eight CAD patients who have been receiving intensive lipid-lowering treatment (niacin 2.5 g/d, lovastatin 40 mg/d, and colestipol 20 g/d) for 10 years in the Familial Atherosclerosis Treatment Study (FATS) follow-up were randomly selected from among 60 such treated patients. Eight CAD patients who were matched to the treated patients for age (±3 years), baseline low density lipoprotein (±5 mg/dL), and triglycerides (±50 mg/dL) but who had never been treated with lipid-lowering drugs were selected as controls. For each of these 32 carotid arteries, luminal and plaque areas were measured by planimetry, in a blinded protocol, from the magnetic resonance image that showed most plaque. Fibrous tissue, calcium, and lipid deposits were identified on the basis of established criteria. Plaque composition was estimated as a fraction of total planimetered area. Patients treated with 10-year intensive lipid-lowering therapy, compared with control subjects, had significantly lower low density lipoprotein cholesterol levels (84 versus 158 mg/dL, respectively; P P 2 , respectively; P =0.01) and lipid composition (1% versus 17%, respectively). Group differences in luminal area (55 [treated] versus 44 [control] mm 2 , P =NS) and plaque area (58 [treated] versus 64 [control] mm 2 , P =NS) tended to favor treatment. MRI appears useful for estimating carotid plaque size and composition. Hyperlipidemic CAD patients frequently (97%) have at least moderate (≥40% area stenosis) carotid plaque. In this case-control study, prolonged intensive lipid-lowering therapy is associated with a markedly decreased lipid content, a characteristic of clinically stable plaques.Keywords
This publication has 40 references indexed in Scilit:
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- High‐resolution MR imaging of human arteriesJournal of Magnetic Resonance Imaging, 1995
- Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content.Heart, 1993
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Nuclear Magnetic Resonance Microscopy of Atheroma in Human Coronary ArteriesAngiology, 1991
- Composition of atherosclerotic plaques in the four major epicardial coronary arteries in patients ≥ 90 years of ageThe American Journal of Cardiology, 1991
- Composition of atherosclerotic plaques in coronary arteries in women <40 years of age with fatal coronary artery disease and implications for plaque reversibilityThe American Journal of Cardiology, 1991
- Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina pectoris with pain at restThe American Journal of Cardiology, 1990
- Can atherosclerotic plaques regress? Anatomic and biochemical evidence from nonhuman animal modelsThe American Journal of Cardiology, 1990
- Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis.Journal of Clinical Investigation, 1984